Clinical Trial: TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748728) titled 'TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs' on July 31.

Brief Summary: This is a randomized, double-blind, placebo-controlled parallel-group Phase II study. The study aims to evaluate the efficacy and safety of TLL-018 in adult patients with moderate to severe active rheumatoid arthritis who have inadequate response or intolerance to conventional synthetic disease-modifying antirheumatic drugs (csDMARDs).

Study Start Date: Aug. 14

Study Type: INTERVENTIONAL

Condition: Rheumatoid Arthritis (RA)

Intervention: DRUG: TLL-018

Treatment group: TLL-018 2...